Hürthle cell carcinoma: Diagnostic and therapeutic implications

World Journal of Surgical Oncology

Volumn 2, Issue , 2004, Pages

  Hanief, Mohamed R ^a   Igali, Laszlo ^b   Grama, Dimitrie ^c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c Sonderborg Hospital   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROXINE;

AGED; ANAMNESIS; ASPIRATION BIOPSY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CASE REPORT; GOITER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HURTHLE CELL CARCINOMA; MALE; METASTASIS; REVIEW; THYROID FOLLICULAR CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY;

EID: 13844297734     PISSN: 14777819     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7819-2-27     Document Type: Review

References (31)

1. Baloch ZW, Mandel S, LiVolsi VA: Combined tall cell carcinoma and Hürthle cell carcinoma (collision tumour) of the thyroid. Arch Pathol Lab Med 2001, 125:541-543.
2. Rosai J, Carcangui ML, DeLellis RA: Tumours of thyroid gland. Atlas of tumour pathology. Series 3, Fasicle 5. Washington, DC: Armed Forces Institute of Pathology 1992.
3. Stojadinovic A, Ghossein RA, Hoos A, Urist MJ, Spiro RH, Shah JP, Brennan MF, Shaha AR, Singh B: Hürthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol 2001, 19: 616-2625.
4. Khafif A, Khafif RA, Attie JN: Hürthle cell carcinoma: A malignancy of low-grade potentia. Head Neck 1999, 21: 06-511.
5. Sanders LE, Silverman M: Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy. Surgery 1998, 124:967-974.
6. McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J: Hürthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery 1996, 120: 000-1004.
7. Bhattacharyya N: Survival and prognosis in Hürthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg 2003, 129:207-210.
8. Stojadinovic A, Hoos A, Ghossein RA, Urist MJ, Leung DH, Spiro RH, Shah JP, Brennan MF, Singh B, Shaha AR: Hürthle cell carcinoma: a 60-year experience. Ann Surg Oncol 2002, 9: 97-203.
9. McIvor NP, Freeman JL, Rosen I, Bedard YC: Value of fine-needle aspiration in the diagnosis of Hürthle cell neoplasms. Head Neck 1993, 15:335-341.
10. Udelsman R, Westra WH, Donovan PI, Sohn TA, Cameron JL: Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 2001, 233: 16-722.
11. Arganini M, Behar R, Wu TC, Straus F, McCormick M, DeGroot LJ, Kaplan EL: Hürthle cell tumours: a twenty-five-year experience. Surgery 1986, 100:1108-1115.
12. Beasley NJ, Walfish PG, Witterick I, Freeman JL: Cause of death in patients with well-differentiated thyroid carcinoma. Laryngoscope 2001, 111:989-991.
13. Grebe SK, Hay ID: Follicular thyroid cancer. Endocrinal Metab Clin North Am 1995, 24:761-801.
14. Berho M, Suster S: The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol 1997, 28:47-53.
15. Tan RK, Finley RK 3rd, Driscoll D, Bakamjian V, Hicks WL Jr, Shedd DP: Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 1995, 17:41-47.
16. Hadar T, Mor C, Shvero J, Levy R, Segal K: Anaplastic carcinoma of the thyroid,. Eur J Surg Oncol 1993, 19: 11-516.
17. Junor EJ, Paul J, Reed NS: Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 1992, 18:83-88.
18. Tyler DS, Winchester DJ, Caraway NP, Hickey RC, Evans DB: Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery 1994, 116:1054-1060.
19. Gundry SR, Burney RE, Thompson NW, Lloyd R: Total thyroidectomy for Hürthle cell neoplasm of the thyroid:. Arch Surg 1983, 118:529-532.
20. Caplan RH, Abellera RM, Kisken WA: Hürthle cell neoplasms of the thyroid gland: reassessment of functional capacity:. Thyroid 1994, 4:243-248.
21. Thompson NW, Dunn EL, Batsakis JG, Nishiyama RH: Hürthle cell lesions of the thyroid gland:. Surg Gynecol Obstet 1974, 139:555-560.
22. McLeod MK, Thompson NW: Hürthle cell neoplasms of the thyroid:. Otolaryngol Clin North Am 1990, 23:441-452.
23. Rosen IB, Luk S, Katz I: Hürthle cell tumour behaviour: dilemma and resolution. Surgery 1985, 98:777-783.
24. 131I ablation for papillary and follicular thyroid carcinoma:. Thyroid 1997, 7: 65-271.
25. Miccoli P, Antonelli A, Spinelli C, Ferdeghini M, Fallahi P, Baschieri L: Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident. Arch Surg 1998, 133:89-93.
26. Vassilopoulou-Sellin R, Klein MJ, Smith TH, et al.: Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer 1993, 71:1348-1352.
27. Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID: The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1998, 83: 195-4199.
28. Sugg SL, Ezzat S, Rosen IB, Freeman JL, Asa SL: Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 1998, 83:4116-4122.
29. Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordonez NG, Sherman SI: Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 2003, 97:1186-94.
30. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C: Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996, 37: 98-605.
31. Vini L, Hyer SL, Marshall J, A'Hern R, Harmer C: Long-term results in elderly patients with differentiated thyroid carcinoma. Cancer 2003, 97:2736-2742.